Results 231 to 240 of about 539,919 (309)
Steroid receptor coactivator‐1 (SRC‐1) reprograms tumor‐associated macrophages (TAMs) via signal transducer and activator of transcription 1(STAT1)‐mediated matrix metallopeptidase 12 (MMP12) transcription to drive perineural invasion (PNI) in pancreatic cancer.
Ke Cheng +9 more
wiley +1 more source
Correction: Emerging strategies in colorectal cancer immunotherapy: enhancing efficacy and survival. [PDF]
Zhang Y +9 more
europepmc +1 more source
Novel viral immune checkpoint K‐TM subunit is aberrantly expressed in CD8+ T cells and enriched in sera of cancer patients, inducing CD8+ T cell anergy and eliciting potent tumor immune escape in mouse model. Mechanistically, K‐TM directly targets and induces the phosphorylation of CD3ε receptor.
Mengyuan Li +13 more
wiley +1 more source
Editorial: Monitoring the immune/tumor microenvironment to improve cancer immunotherapy. [PDF]
Kim J, Kubelick KP.
europepmc +1 more source
Genome‐wide CRISPR/Cas9 based screening identified RELA as a key tumor suppressor in TP53R249S‐mutant HCC. Its loss promotes tumorigenesis and metastasis via DVL1‐mediated Wnt/β‐catenin activation, while its agonist betulinic acid suppresses tumor progression.
Zhiping Wu +17 more
wiley +1 more source
CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge. [PDF]
Guo X, Fu Y, Baran N, Ma W.
europepmc +1 more source

